James William Kupiec - Apr 18, 2024 Form 4 Insider Report for CASSAVA SCIENCES INC (SAVA)

Role
Chief Medical Officer
Signature
/s/ Eric J. Schoen by Power of Attorney
Stock symbol
SAVA
Transactions as of
Apr 18, 2024
Transactions value $
$33,000
Form type
4
Date filed
4/22/2024, 09:19 AM
Previous filing
Oct 4, 2023
Next filing
May 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SAVA Common Stock Options Exercise $33K +1.5K +60% $22.00 4K Apr 18, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SAVA Common Stock Warrant Award $0 +1K $0.00 1K Jan 3, 2024 Common Stock 1.5K $33.00 Direct F1
transaction SAVA Common Stock Warrant Options Exercise $0 -1K -100% $0.00* 0 Apr 18, 2024 Common Stock 1.5K $33.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents warrants that were originally issued on January 3, 2024 as a distribution to all holders of common shares. Each warrant entitles the holder to purchase one and one-half common shares at an exercise price of $33.00 per warrant. This distribution was exempt from immediate reporting under Section 16.
F2 Form 4 represents exercise for cash of common stock warrants received on January 3, 2024. Holder received one and one-half shares of common stock for each common stock warrant exercised.